Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB00728"

No prefix for http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/.

Predicate	Value (sorted: none)
owl:sameAs	?:Clindamycin
owl:sameAs	?:Netilmicin
owl:sameAs	?:Piperacillin
rdf:type	ns1:drugs
owl:sameAs	?:DBSALT000575
owl:sameAs	?:Colistimethate
owl:sameAs	?:Gentamicin
owl:sameAs	?:Rocuronium
owl:sameAs	?:Lincomycin
owl:sameAs	?:Tobramycin
ns1:interactsWith	?:Clindamycin
ns1:interactsWith	?:Netilmicin
ns1:interactsWith	?:Amikacin
ns1:drugCategory	?:Muscle relaxant, Skeletal
owl:sameAs	?:APRD01221
owl:sameAs	?:Amikacin
rdfs:label	"Rocuronium"
ns1:interactsWith	?:Piperacillin
ns1:interactsWith	?:Gentamicin
owl:sameAs	?:DBMET00673
ns1:description	"Rocuronium (rapid onset-curonium) is a desacetoxy analogue of vecuronium with a more rapid onset of action. It is an aminosteroid non-depolarizing neuromuscular blocker or muscle relaxant used in modern anaesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Introduced in 1994, rocuronium has rapid onset, and intermediate duration of action. It is marketed under the trade name of Zemuron in the United States and Esmeron in most other countries. There is considered to be a risk of allergic reaction to the drug in some patients (particularly those with asthma), but a similar incidence of allergic reactions has been observed by using other members of the same drug class (non-depolarizing neuromuscular blocking drugs). The γ-cyclodextrin derivative sugammadex (trade name Bridion) has been recently introduced as a novel agent to reverse the action of rocuronium."
ns1:interactsWith	?:Tobramycin
ns1:interactsWith	?:Colistimethate
ns1:interactsWith	?:Lincomycin

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/drugbank_small.nt

The resource appears as object in 17 triples

Context graph